Indefinite Delivery Contract SPE2DU25D9382

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers worldwide. The $4,999,999 IDC, valid through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The IDC was awarded under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple regional Prime Vendor Contracts to provide worldwide pharmaceutical support to the Defense Health Agency, Department of Defense customers, the United States Coast Guard, and other designated providers. The $30.3 billion unrestricted and fully competitive acquisition will have a 30-month base period and three 30-month option periods, with awards made to the responsive and responsible offerors providing the lowest overall distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.